Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Phase I study of suramin administered by intermittent infusion without adaptive control to cancer patients: update of two expanded dose levels near the maximally tolerated dose.
Adjuvant and neoadjuvant therapy for early-stage non-small-cell lung cancer.
Differential fMRI BOLD responses in amygdala in intermittent explosive disorder as a function of past Alcohol Use Disorder.
The Influence of Host Stress on the Mechanism of Infection: Lost Microbiomes, Emergent Pathobiomes, and the Role of Interkingdom Signaling.
Long-Term Outcomes With Teduglutide From a Single Center.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Long-Term Outcomes With Teduglutide From a Single Center.
Long-Term Outcomes With Teduglutide From a Single Center. JPEN J Parenter Enteral Nutr. 2021 02; 45(2):318-322.
View in:
PubMed
subject areas
Gastrointestinal Agents
Humans
Peptides
Retrospective Studies
Short Bowel Syndrome
authors with profiles
Dejan Micic
Carol Semrad